Intuitive Surgical, Inc. Logo

Intuitive Surgical, Inc.

ISRG

(1.5)
Stock Price

527,61 USD

12.87% ROA

15.36% ROE

81.52x PER

Market Cap.

170.848.872.890,00 USD

0.58% DER

0% Yield

27.65% NPM

Intuitive Surgical, Inc. Stock Analysis

Intuitive Surgical, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Intuitive Surgical, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

ROE in an average range (12.93%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (1.514), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (8.56x) suggests it's overvalued, potentially making it an expensive investment.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Intuitive Surgical, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Intuitive Surgical, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Intuitive Surgical, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Intuitive Surgical, Inc. Revenue
Year Revenue Growth
1998 0
1999 10.192.000 100%
2000 26.624.000 61.72%
2001 51.673.000 48.48%
2002 72.022.000 28.25%
2003 91.675.000 21.44%
2004 138.803.000 33.95%
2005 227.338.000 38.94%
2006 372.682.000 39%
2007 600.828.000 37.97%
2008 874.919.000 31.33%
2009 1.052.168.000 16.85%
2010 1.413.000.000 25.54%
2011 1.757.300.000 19.59%
2012 2.178.800.000 19.35%
2013 2.265.100.000 3.81%
2014 2.131.700.000 -6.26%
2015 2.384.400.000 10.6%
2016 2.704.400.000 11.83%
2017 3.128.900.000 13.57%
2018 3.724.200.000 15.98%
2019 4.478.500.000 16.84%
2020 4.358.400.000 -2.76%
2021 5.710.100.000 23.67%
2022 6.222.200.000 8.23%
2023 6.974.800.000 10.79%
2023 7.124.100.000 2.1%
2024 8.039.600.000 11.39%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Intuitive Surgical, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1998 23.208.000
1999 11.130.000 -108.52%
2000 11.734.000 5.15%
2001 13.851.000 15.28%
2002 16.793.000 17.52%
2003 16.190.000 -3.72%
2004 17.812.000 9.11%
2005 17.354.000 -2.64%
2006 29.778.000 41.72%
2007 48.859.000 39.05%
2008 79.372.000 38.44%
2009 95.102.000 16.54%
2010 116.000.000 18.02%
2011 140.200.000 17.26%
2012 170.000.000 17.53%
2013 167.700.000 -1.37%
2014 178.000.000 5.79%
2015 197.400.000 9.83%
2016 239.600.000 17.61%
2017 328.600.000 27.08%
2018 418.100.000 21.41%
2019 557.300.000 24.98%
2020 595.100.000 6.35%
2021 671.000.000 11.31%
2022 879.000.000 23.66%
2023 997.600.000 11.89%
2023 998.800.000 0.12%
2024 1.120.400.000 10.85%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Intuitive Surgical, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1998 0
1999 0 0%
2000 19.136.000 100%
2001 29.987.000 36.19%
2002 40.864.000 26.62%
2003 39.719.000 -2.88%
2004 48.994.000 18.93%
2005 67.443.000 27.35%
2006 110.703.000 39.08%
2007 158.685.000 30.24%
2008 230.570.000 31.18%
2009 278.511.000 17.21%
2010 358.800.000 22.38%
2011 438.800.000 18.23%
2012 522.200.000 15.97%
2013 574.000.000 9.02%
2014 691.000.000 16.93%
2015 640.500.000 -7.88%
2016 705.300.000 9.19%
2017 810.900.000 13.02%
2018 986.600.000 17.81%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Intuitive Surgical, Inc. EBITDA
Year EBITDA Growth
1998 -30.773.000
1999 -17.306.000 -77.82%
2000 -17.417.000 0.64%
2001 -15.713.000 -10.84%
2002 -15.627.000 -0.55%
2003 -1.645.000 -849.97%
2004 28.053.000 105.86%
2005 76.016.000 63.1%
2006 142.624.000 46.7%
2007 219.769.000 35.1%
2008 335.919.000 34.58%
2009 377.439.000 11%
2010 555.200.000 32.02%
2011 694.800.000 20.09%
2012 878.100.000 20.87%
2013 852.500.000 -3%
2014 544.800.000 -56.48%
2015 740.000.000 26.38%
2016 945.200.000 21.71%
2017 1.054.600.000 10.37%
2018 1.199.400.000 12.07%
2019 1.374.500.000 12.74%
2020 1.049.800.000 -30.93%
2021 1.821.000.000 42.35%
2022 1.577.100.000 -15.47%
2023 2.297.600.000 31.36%
2023 2.188.600.000 -4.98%
2024 2.716.400.000 19.43%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Intuitive Surgical, Inc. Gross Profit
Year Gross Profit Growth
1998 0
1999 3.162.000 100%
2000 13.345.000 76.31%
2001 23.455.000 43.1%
2002 37.438.000 37.35%
2003 44.029.000 14.97%
2004 87.990.000 49.96%
2005 153.569.000 42.7%
2006 247.836.000 38.04%
2007 414.286.000 40.18%
2008 620.777.000 33.26%
2009 751.052.000 17.35%
2010 1.030.000.000 27.08%
2011 1.273.800.000 19.14%
2012 1.570.300.000 18.88%
2013 1.594.200.000 1.5%
2014 1.413.800.000 -12.76%
2015 1.577.900.000 10.4%
2016 1.890.100.000 16.52%
2017 2.194.100.000 13.86%
2018 2.604.100.000 15.74%
2019 3.110.200.000 16.27%
2020 2.861.200.000 -8.7%
2021 3.958.500.000 27.72%
2022 4.196.000.000 5.66%
2023 4.668.800.000 10.13%
2023 4.729.500.000 1.28%
2024 5.490.800.000 13.87%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Intuitive Surgical, Inc. Net Profit
Year Net Profit Growth
1998 -29.443.000
1999 -18.415.000 -59.89%
2000 -18.523.000 0.58%
2001 -16.700.000 -10.92%
2002 -18.421.000 9.34%
2003 -9.623.000 -91.43%
2004 23.478.000 140.99%
2005 94.134.000 75.06%
2006 72.044.000 -30.66%
2007 144.537.000 50.16%
2008 204.315.000 29.26%
2009 232.606.000 12.16%
2010 381.800.000 39.08%
2011 495.100.000 22.88%
2012 656.600.000 24.6%
2013 671.000.000 2.15%
2014 418.800.000 -60.22%
2015 588.800.000 28.87%
2016 735.900.000 19.99%
2017 660.000.000 -11.5%
2018 1.127.900.000 41.48%
2019 1.379.300.000 18.23%
2020 1.060.600.000 -30.05%
2021 1.704.600.000 37.78%
2022 1.322.300.000 -28.91%
2023 1.662.800.000 20.48%
2023 1.798.000.000 7.52%
2024 2.107.600.000 14.69%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Intuitive Surgical, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1998 -2
1999 -1 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 1 0%
2009 1 0%
2010 1 100%
2011 1 0%
2012 2 0%
2013 2 0%
2014 1 0%
2015 2 0%
2016 2 50%
2017 2 -100%
2018 3 66.67%
2019 4 0%
2020 3 0%
2021 5 25%
2022 4 -33.33%
2023 5 25%
2023 5 20%
2024 6 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Intuitive Surgical, Inc. Free Cashflow
Year Free Cashflow Growth
1999 -16.858.000
2000 -16.359.000 -3.05%
2001 -24.080.000 32.06%
2002 -19.936.000 -20.79%
2003 -10.379.000 -92.08%
2004 7.876.000 231.78%
2005 40.733.000 80.66%
2006 81.791.000 50.2%
2007 181.680.000 54.98%
2008 172.262.000 -5.47%
2009 331.639.000 48.06%
2010 432.000.000 23.23%
2011 594.700.000 27.36%
2012 672.400.000 11.56%
2013 775.400.000 13.28%
2014 559.500.000 -38.59%
2015 690.900.000 19.02%
2016 989.000.000 30.14%
2017 953.200.000 -3.76%
2018 982.200.000 2.95%
2019 1.172.600.000 16.24%
2020 1.143.300.000 -2.56%
2021 1.735.900.000 34.14%
2022 958.400.000 -81.12%
2023 749.600.000 -27.85%
2023 292.100.000 -156.62%
2024 311.100.000 6.11%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Intuitive Surgical, Inc. Operating Cashflow
Year Operating Cashflow Growth
1999 -15.927.000
2000 -12.804.000 -24.39%
2001 -18.553.000 30.99%
2002 -14.148.000 -31.14%
2003 -7.854.000 -80.14%
2004 30.315.000 125.91%
2005 70.787.000 57.17%
2006 99.845.000 29.1%
2007 205.687.000 51.46%
2008 278.235.000 26.07%
2009 385.055.000 27.74%
2010 528.000.000 27.07%
2011 677.600.000 22.08%
2012 814.200.000 16.78%
2013 880.000.000 7.48%
2014 665.100.000 -32.31%
2015 771.900.000 13.84%
2016 1.042.900.000 25.99%
2017 1.143.900.000 8.83%
2018 1.169.600.000 2.2%
2019 1.598.200.000 26.82%
2020 1.484.800.000 -7.64%
2021 2.089.400.000 28.94%
2022 1.490.800.000 -40.15%
2023 1.813.800.000 17.81%
2023 548.400.000 -230.74%
2024 620.500.000 11.62%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Intuitive Surgical, Inc. Capital Expenditure
Year Capital Expenditure Growth
1999 931.000
2000 3.555.000 73.81%
2001 5.527.000 35.68%
2002 5.788.000 4.51%
2003 2.525.000 -129.23%
2004 22.439.000 88.75%
2005 30.054.000 25.34%
2006 18.054.000 -66.47%
2007 24.007.000 24.8%
2008 105.973.000 77.35%
2009 53.416.000 -98.39%
2010 96.000.000 44.36%
2011 82.900.000 -15.8%
2012 141.800.000 41.54%
2013 104.600.000 -35.56%
2014 105.600.000 0.95%
2015 81.000.000 -30.37%
2016 53.900.000 -50.28%
2017 190.700.000 71.74%
2018 187.400.000 -1.76%
2019 425.600.000 55.97%
2020 341.500.000 -24.63%
2021 353.500.000 3.39%
2022 532.400.000 33.6%
2023 1.064.200.000 49.97%
2023 256.300.000 -315.22%
2024 309.400.000 17.16%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Intuitive Surgical, Inc. Equity
Year Equity Growth
1998 20.596.000
1999 22.211.000 7.27%
2000 90.730.000 75.52%
2001 78.293.000 -15.89%
2002 63.680.000 -22.95%
2003 278.957.000 77.17%
2004 314.932.000 11.42%
2005 442.591.000 28.84%
2006 589.705.000 24.95%
2007 888.674.000 33.64%
2008 1.266.766.000 29.85%
2009 1.537.283.000 17.6%
2010 2.037.400.000 24.55%
2011 2.645.600.000 22.99%
2012 3.580.100.000 26.1%
2013 3.501.400.000 -2.25%
2014 3.379.400.000 -3.61%
2015 4.319.500.000 21.76%
2016 5.777.800.000 25.24%
2017 4.728.400.000 -22.19%
2018 6.696.200.000 29.39%
2019 8.305.600.000 19.38%
2020 9.786.700.000 15.13%
2021 12.001.900.000 18.46%
2022 11.183.300.000 -7.32%
2023 13.397.300.000 16.53%
2023 12.623.500.000 -6.13%
2024 14.796.500.000 14.69%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Intuitive Surgical, Inc. Assets
Year Assets Growth
1998 28.167.000
1999 34.455.000 18.25%
2000 112.421.000 69.35%
2001 100.361.000 -12.02%
2002 91.581.000 -9.59%
2003 314.994.000 70.93%
2004 354.229.000 11.08%
2005 501.587.000 29.38%
2006 671.790.000 25.34%
2007 1.039.998.000 35.4%
2008 1.474.624.000 29.47%
2009 1.809.716.000 18.52%
2010 2.390.400.000 24.29%
2011 3.063.100.000 21.96%
2012 4.059.200.000 24.54%
2013 3.950.300.000 -2.76%
2014 3.959.400.000 0.23%
2015 4.907.300.000 19.32%
2016 6.486.900.000 24.35%
2017 5.758.000.000 -12.66%
2018 7.846.700.000 26.62%
2019 9.733.200.000 19.38%
2020 11.168.900.000 12.85%
2021 13.555.000.000 17.6%
2022 12.974.000.000 -4.48%
2023 15.441.500.000 15.98%
2023 14.712.700.000 -4.95%
2024 16.649.900.000 11.63%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Intuitive Surgical, Inc. Liabilities
Year Liabilities Growth
1998 2.438.000
1999 12.244.000 80.09%
2000 21.691.000 43.55%
2001 22.068.000 1.71%
2002 27.901.000 20.91%
2003 36.037.000 22.58%
2004 39.297.000 8.3%
2005 58.996.000 33.39%
2006 82.085.000 28.13%
2007 151.324.000 45.76%
2008 207.858.000 27.2%
2009 272.433.000 23.7%
2010 353.000.000 22.82%
2011 417.500.000 15.45%
2012 479.100.000 12.86%
2013 448.900.000 -6.73%
2014 580.000.000 22.6%
2015 587.800.000 1.33%
2016 709.100.000 17.11%
2017 1.031.200.000 31.24%
2018 1.159.200.000 11.04%
2019 1.448.500.000 19.97%
2020 1.409.800.000 -2.75%
2021 1.603.500.000 12.08%
2022 1.861.400.000 13.86%
2023 2.044.200.000 8.94%
2023 2.089.200.000 2.15%
2024 1.853.400.000 -12.72%

Intuitive Surgical, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
21.33
Net Income per Share
5.9
Price to Earning Ratio
81.52x
Price To Sales Ratio
22.56x
POCF Ratio
118.86
PFCF Ratio
885.69
Price to Book Ratio
11.6
EV to Sales
22.16
EV Over EBITDA
69.76
EV to Operating CashFlow
116.86
EV to FreeCashFlow
869.94
Earnings Yield
0.01
FreeCashFlow Yield
0
Market Cap
170,85 Bil.
Enterprise Value
167,81 Bil.
Graham Number
74.15
Graham NetNet
12.76

Income Statement Metrics

Net Income per Share
5.9
Income Quality
0.68
ROE
0.15
Return On Assets
0.13
Return On Capital Employed
0.13
Net Income per EBT
0.94
EBT Per Ebit
1.14
Ebit per Revenue
0.26
Effective Tax Rate
0.05

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.14
Stock Based Compensation to Revenue
0.08
Gross Profit Margin
0.67
Operating Profit Margin
0.26
Pretax Profit Margin
0.29
Net Profit Margin
0.28

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
4.05
Free CashFlow per Share
0.54
Capex to Operating CashFlow
0.87
Capex to Revenue
0.16
Capex to Depreciation
2.74
Return on Invested Capital
0.12
Return on Tangible Assets
0.13
Days Sales Outstanding
59.92
Days Payables Outstanding
28.27
Days of Inventory on Hand
201.26
Receivables Turnover
6.09
Payables Turnover
12.91
Inventory Turnover
1.81
Capex per Share
3.5

Balance Sheet

Cash per Share
13,40
Book Value per Share
41,68
Tangible Book Value per Share
40.62
Shareholders Equity per Share
41.43
Interest Debt per Share
0.32
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
-1.26
Current Ratio
5.15
Tangible Asset Value
14,42 Bil.
Net Current Asset Value
5,80 Bil.
Invested Capital
10660300000
Working Capital
6,17 Bil.
Intangibles to Total Assets
0.02
Average Receivables
1,25 Bil.
Average Payables
0,19 Bil.
Average Inventory
1341600000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Intuitive Surgical, Inc. Dividends
Year Dividends Growth

Intuitive Surgical, Inc. Profile

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

CEO
Dr. Gary S. Guthart Ph.D.
Employee
13.676
Address
1020 Kifer Road
Sunnyvale, 94086-5304

Intuitive Surgical, Inc. Executives & BODs

Intuitive Surgical, Inc. Executives & BODs
# Name Age
1 Mr. Henry L. Charlton
Senior Vice President & Chief Commercial and Marketing Officer
70
2 Mr. Marshall L. Mohr
Executive Vice President of Global Business Services
70
3 Mr. Fredrik Widman
Vice President, Principal Accounting Officer & Corporate Controller
70
4 Mr. Gary H. Loeb J.D.
Senior Vice President, General Counsel & Chief Compliance Officer
70
5 Dr. Gary S. Guthart Ph.D.
Chief Executive Officer & Director
70
6 Mr. Jamie E. Samath
Senior Vice President & Chief Financial Officer
70
7 Mr. Brian King
Vice President, Treasurer & Head of Investor Relations
70
8 Mr. David J. Rosa
President & Director
70
9 Mr. Robert DeSantis
Executive Vice President and Chief Strategy & Corporate Operations Officer
70
10 Dr. Christopher R. Carlson Ph.D.
Executive Vice President of Research, Corporate Development & Intuitive Ventures
70

Intuitive Surgical, Inc. Competitors